Ursula Müller‐Vieira

Publications by Year

Research Areas

Pharmacogenetics and Drug Metabolism, Hormonal Regulation and Hypertension, Estrogen and related hormone effects, Liver physiology and pathology, 3D Printing in Biomedical Research

Most-Cited Works

• → HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro(2010)223 cited
• → Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity(2013)122 cited
• → Synthesis and Evaluation of Heteroaryl-Substituted Dihydronaphthalenes and Indenes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2) for the Treatment of Congestive Heart Failure and Myocardial Fibrosis(2006)107 cited
• → Selectivity and potency of the retroprogesterone dydrogesterone in vitro(2011)88 cited
• → Design, Synthesis, and Biological Evaluation of (Hydroxyphenyl)naphthalene and -quinoline Derivatives: Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases(2008)86 cited
• → Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure(2007)83 cited
• → Towards an Extended Functional Hepatocyte In Vitro Culture(2008)82 cited
• → Synthesis and Evaluation of (Pyridylmethylene)tetrahydronaphthalenes/-indanes and Structurally Modified Derivatives: Potent and Selective Inhibitors of Aldosterone Synthase(2005)80 cited
• → Heteroaryl-Substituted Naphthalenes and Structurally Modified Derivatives: Selective Inhibitors of CYP11B2 for the Treatment of Congestive Heart Failure and Myocardial Fibrosis(2005)80 cited
• → Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls(2009)70 cited